Not Yet RecruitingPhase 4ACTRN12622001483741

Nebulised fentanyl for labour pain in low risk patients– a pharmacokinetic and feasibility study

Nebulised fentanyl for labour pain – a pharmacokinetic and feasibility study in low risk pregnant patients


Sponsor

The Royal Brisbane and Women's Hospital

Enrollment

15 participants

Start Date

Feb 1, 2023

Study Type

Interventional

Conditions

Summary

Labour and birth can be painful experiences. In Australia, 53% of labouring women use inhaled nitrous oxide. The widespread use of nitrous oxide is currently being reconsidered due to environmental concerns. Without nitrous oxide, there would not be a widely available self-administered, needle-free method of pharmacological labour analgesia. In this pharmacokinetic study, we will evaluate the use of nebulised fentanyl for labour analgesia, obtaining maternal and cord blood samples to measure concentrations in the mother and baby. This will be used to develop a proposed dosing schedule. We will also evaluate patient and midwife experiences. This preliminary research will lead to dosing recommendations and larger clinical evaluations, aiming to provide an additional needle-free option for labour analgesia across Australia.


Eligibility

Sex: FemalesMin Age: 18 YearssMax Age: 50 Yearss

Inclusion Criteria2

  • Age greater than or equal to 18 years and less than or equal to 50 years, gestation greater than or equal to 37 weeks, early pregnancy body mass index greater than or equal to 16 and less than or equal to 40 kg/m2, planning a vaginal delivery or a vaginal birth after caesarean section, able to understand information and consent form in English and provide informed consent.
  • Midwives who are providing clinical care for participants will be offered the opportunity to voluntarily and in a de-identified fashion to provide feedback on the use of nebulised fentanyl.

Exclusion Criteria1

  • Multiple pregnancy, fetus with congenital anomaly, pre-eclampsia, cardiovascular or respiratory disease with New York Heart Association (NYHA) score >2, epilepsy on medication, diabetes on medication, elevated serum creatinine (>70 µmol/L), known opioid misuse, allergy to fentanyl, fentanyl administered by any route in the 24 hours prior to active labour.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Fentanyl 2 mcg/mL administered over 3-5 minutes by an Aerogen ultra nebuliser. Once only administration, in the first stage of labour, when pain relief is requested. Aerogen uses an electrostatic ch

Fentanyl 2 mcg/mL administered over 3-5 minutes by an Aerogen ultra nebuliser. Once only administration, in the first stage of labour, when pain relief is requested. Aerogen uses an electrostatic charge to nebulise, not a carrier gas.


Locations(1)

Royal Brisbane & Womens Hospital - Herston

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12622001483741